Every Form 4 that Adagene Inc. (ADAG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ADAG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ADAG filings page.
Adagene Inc. Executive Director of Finance Chunfang Gu had 6,250 ADSs vest on July 23, 2026; 475 ADSs were sold for tax withholding, resulting in 5,775 ADSs received. The 6,250 ADSs were equivalent to 7,813 RSUs on an ordinary share basis. As of September 30, 2026, Gu directly held 5,775 ADSs and 15,625 RSUs, granted under the 2021 Performance Incentive Plan.
Adagene Inc. Chief Financial Officer and director Tam Man Kin purchased 2,000 ADSs in the open market at $3 per ADS on September 23, 2026. His directly held ADS position was 12,000 ADSs after the purchase. A separate holding entry reports 25,000 restricted stock units directly; a footnote states they were granted under the 2021 Performance Incentive Plan in July 2024 and identifies remaining RSU vesting dates of July 23, 2027 and July 23, 2028. No Rule 10b5-1 plan is reported.
Adagene Inc. (ADAG) reported that Chief Executive Officer and director Peter Luo purchased American Depositary Shares (ADS) of the company on September 16, 2026. He acquired 20,290 ADS in an open-market or private transaction at an average price of $3.1533 per ADS, with individual trade prices ranging from $3.00 to $3.20 per ADS. Following this purchase, he directly holds 88,535 ADS. No Rule 10b5-1 trading plan is reported for this transaction.
Adagene Inc. (ADAG) reported that director Do Cuong V purchased American Depositary Shares in the company. On 2026-08-14, the reporting person bought 2,000 ADS in open-market or private transactions at a price of $3.75 per ADS, resulting in direct ownership of 2,000 ADS.
Adagene Inc. director Zhu Li received a grant of 20,000 nonqualified stock options on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan. The options have an exercise price of $3.00 per ordinary share, expire on August 13, 2036, and increase Li’s directly held option position to 90,000 options.
According to the grant terms, the options will vest on April 30, 2027 or on the date of the next Form 20-F filing, whichever occurs earlier, tying vesting to a specific future company reporting milestone.
Adagene Inc. director Cheung Andy Yiu Leung received a grant of 20,000 nonqualified stock options on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan. The options have a $3.00 per-share exercise price, expire on August 13, 2036, and will vest on April 30, 2027 or the date of the next annual 20-F filing, whichever is earlier. Following this award, Cheung holds 90,000 options in total. The Rule 10b5-1 checkbox was not marked as being under a trading plan.
Adagene Inc. director Do Cuong V received a grant of 20,000 nonqualified stock options on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan. The options have an exercise price of $3.00 per ordinary share and expire on August 13, 2036. They vest on April 30, 2027 or the date of the next Form 20-F filing, whichever is earlier. Following this award, the reporting person holds a total of 110,000 derivative securities related to Adagene ordinary shares.
Adagene Inc. reported that director Ulf Grawunder received a grant of 20,000 nonqualified stock options on 2026-08-13. The options carry an exercise price of $3.00 per ordinary share and expire on 2036-08-13. Following this grant, Grawunder holds 85,000 options in total, and the transaction is indicated as made under a Rule 10b5-1 trading plan.
Adagene Inc. director and Chief Executive Officer Peter Luo reported open-market purchases of a total of 23,245 American Depositary Shares (ADS). On 2026-08-04, he bought 22,966 ADS at an average price of $3.6465 per ADS, with individual trades between $3.62 and $3.65. On 2026-08-05, he purchased a further 279 ADS at $3.65 per ADS. The filing also reports 112,500 Restricted Stock Units (RSUs) granted under the Adagene Inc. 2021 Performance Incentive Plan, with 56,250 RSUs scheduled to vest on each of 7/23/2027 and 7/23/2028. These trades were not flagged as made under a Rule 10b5-1 trading plan.